bpc-157 body protection compound-157 pentadecapeptide gastric juice – Mark Hyman, MD Stable Gastric Pentadecapeptide BPC 157

The Research Gap Phase I safety trials have been conducted but results were never published despite completed status

4 BiaginiG.BabinskiK.AvoliM.MarcinkiewiczM.SeguelaP

Complete healing depends on injury severity, but BPC-157 can reduce recovery time by 40-50%

Prefer treatments researched in human fertility populations

Together, they may reduce hunger, decrease cravings, and improve portion control, which can make a caloriereduced eating plan easier to follow

Gastrointestinal Protection Multiple studies showed cytoprotective effects against: NSAID-induced gastric lesions Alcohol-induced mucosal damage Reference: Sikiric et al., 2013 BPC 157 in Research Stacks (Wolverine Stack) Within research communities, BPC-157 peptides are sometimes grouped with TB-500 in what is informally referred to as the wolverine stack. This terminology reflects: Observed tissue repair activity Angiogenic support Regenerative properties in animal models It is not a medical classification, but rather research shorthand